30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Onaiza Cadoret-Manier

Insider profile

Currently holds positions in Ionis Pharmaceuticals Inc and Ardelyx Inc

Performance

Overall performance
3.5

Performance over holding periods
3.5
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 86% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chief Corporate Development and Commercial Officer Ionis Pharmaceuticals Inc Jan. 9, 2020 -
Independent Director Ardelyx Inc March 12, 2020 -

Onaiza Cadoret-Manier's trades of Ionis Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-02 2024-02-02 PrS Proposed sale
82,963
404.85
US$3,252,687
82,963 404.85 US$3,252,687
2024-02-02 2024-02-02 S Sale
8,835 +45.4%
360.64
US$2,005,873
8,835 +45.4% 360.64 US$2,005,873
2024-09-04 2024-02-01 PrS Proposed sale
12,490
222.81
US$1,352,868
12,490 222.81 US$1,352,868
2024-01-18 2024-01-17 S Sale
5,564 -14.1%
50.42
US$280,520
5,564 -14.1% 50.42 US$280,520
2024-01-17 2024-01-17 PrS Proposed sale
5,564
50.54
US$281,202
5,564 50.54 US$281,202
2023-04-19 2023-04-18 S Sale
2,582 -9.6%
36.50
US$94,250
2,582 -9.6% 36.50 US$94,250
2023-04-17 2023-04-18 PrS Proposed sale
2,743
37.78
US$103,631
2,743 37.78 US$103,631
2023-02-07 2023-02-06 PrS Proposed sale
1,451
40.69
US$59,044
1,451 40.69 US$59,044
2023-02-07 2023-02-06 S Sale
1,451 -6.4%
40.66
US$58,997
1,451 -6.4% 40.66 US$58,997
2023-01-19 2023-01-18 PrS Proposed sale
4,200
41.00
US$172,200
4,200 41.00 US$172,200
2023-01-19 2023-01-18 S Sale
3,748 -16.8%
39.55
US$148,223
3,748 -16.8% 39.55 US$148,223